These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36573964)

  • 1. Targeting ULK1 Decreases IFNγ-Mediated Resistance to Immune Checkpoint Inhibitors.
    Fenton SE; Zannikou M; Ilut L; Fischietti M; Ji C; Oku CV; Horvath CM; Le Poole IC; Bosenberg M; Bartom ET; Kocherginsky M; Platanias LC; Saleiro D
    Mol Cancer Res; 2023 Apr; 21(4):332-344. PubMed ID: 36573964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
    Wu R; Wang C; Li Z; Xiao J; Li C; Wang X; Kong P; Cao J; Huang F; Li Z; Huang Y; Chen Y; Li X; Yang D; Zhang H; Mai J; Feng G; Deng R; Zhu X
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33158915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.
    Rothschild SI; Gautschi O; Batliner J; Gugger M; Fey MF; Tschan MP
    Lung Cancer; 2017 May; 107():73-83. PubMed ID: 27372519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1.
    Lv P; Luo YF; Zhou WY; Liu B; Zhou Z; Shi YZ; Huang R; Peng C; He ZL; Wang J; Zhang HH; Nie SD
    Kaohsiung J Med Sci; 2020 Jun; 36(6):429-440. PubMed ID: 32125086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamical modeling of proliferative-invasive plasticity and IFNγ signaling in melanoma reveals mechanisms of PD-L1 expression heterogeneity.
    Subhadarshini S; Sahoo S; Debnath S; Somarelli JA; Jolly MK
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37678920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central role of ULK1 in type I interferon signaling.
    Saleiro D; Mehrotra S; Kroczynska B; Beauchamp EM; Lisowski P; Majchrzak-Kita B; Bhagat TD; Stein BL; McMahon B; Altman JK; Kosciuczuk EM; Baker DP; Jie C; Jafari N; Thompson CB; Levine RL; Fish EN; Verma AK; Platanias LC
    Cell Rep; 2015 Apr; 11(4):605-17. PubMed ID: 25892232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models.
    Wong CW; Evangelou C; Sefton KN; Leshem R; Zhang W; Gopalan V; Chattrakarn S; Fernandez Carro ML; Uzuner E; Mole H; Wilcock DJ; Smith MP; Sergiou K; Telfer BA; Isaac DT; Liu C; Perl NR; Marie K; Lorigan P; Williams KJ; Rao PE; Nagaraju RT; Niepel M; Hurlstone AFL
    Nat Commun; 2023 Sep; 14(1):5983. PubMed ID: 37752135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.
    Jiang J; Ding Y; Wu M; Chen Y; Lyu X; Lu J; Wang H; Teng L
    Cancer Med; 2020 Nov; 9(22):8498-8518. PubMed ID: 32969604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment.
    Nguyen TT; Ramsay L; Ahanfeshar-Adams M; Lajoie M; Schadendorf D; Alain T; Watson IR
    Clin Cancer Res; 2021 Jun; 27(12):3432-3442. PubMed ID: 33593882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care.
    Singh S; Numan A; Agrawal N; Tambuwala MM; Singh V; Kesharwani P
    Int Immunopharmacol; 2020 Jun; 83():106417. PubMed ID: 32200155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.
    Tang F; Hu P; Yang Z; Xue C; Gong J; Sun S; Shi L; Zhang S; Li Z; Yang C; Zhang J; Xie C
    Oncol Rep; 2017 Jun; 37(6):3449-3458. PubMed ID: 28498429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418
    [No Abstract]   [Full Text] [Related]  

  • 14. Digitoxin Suppresses Human Cytomegalovirus Replication via Na
    Mukhopadhyay R; Venkatadri R; Katsnelson J; Arav-Boger R
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures.
    Hossain SM; Gimenez G; Stockwell PA; Tsai P; Print CG; Rys J; Cybulska-Stopa B; Ratajska M; Harazin-Lechowska A; Almomani S; Jackson C; Chatterjee A; Eccles MR
    Front Immunol; 2022; 13():955063. PubMed ID: 36248850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Autophagy-Initiating Protein Kinase ULK1 Phosphorylates Human Cytomegalovirus Tegument Protein pp28 and Regulates Efficient Virus Release.
    König P; Svrlanska A; Read C; Feichtinger S; Stamminger T
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33328309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia.
    Han SH; Korm S; Han YG; Choi SY; Kim SH; Chung HJ; Park K; Kim JY; Myung K; Lee JY; Kim H; Kim DW
    Autophagy; 2019 Dec; 15(12):2076-2090. PubMed ID: 30929559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma.
    Zhang W; Xia H; Yang R; Zhang Y; Zheng Q; Shang X; Liu N; Ma X; Wei C; Chen H; Mu X; Wang X; Liu Y
    Front Immunol; 2022; 13():1030969. PubMed ID: 36426352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Checkpoint Inhibitors and RAS-ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma.
    Morante M; Pandiella A; Crespo P; Herrero A
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aconitine induces autophagy via activating oxidative DNA damage-mediated AMPK/ULK1 signaling pathway in H9c2 cells.
    Wang W; Jiang J; Huang Y; Peng F; Hu T; Wu J; Pan X; Rao C
    J Ethnopharmacol; 2022 Jan; 282():114631. PubMed ID: 34520828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.